160 related articles for article (PubMed ID: 18199767)
1. Antiapoptotic and trophic effects of dominant-negative forms of dual leucine zipper kinase in dopamine neurons of the substantia nigra in vivo.
Chen X; Rzhetskaya M; Kareva T; Bland R; During MJ; Tank AW; Kholodilov N; Burke RE
J Neurosci; 2008 Jan; 28(3):672-80. PubMed ID: 18199767
[TBL] [Abstract][Full Text] [Related]
2. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
Saporito MS; Brown EM; Miller MS; Carswell S
J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
[TBL] [Abstract][Full Text] [Related]
3. CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism.
Silva RM; Ries V; Oo TF; Yarygina O; Jackson-Lewis V; Ryu EJ; Lu PD; Marciniak SJ; Ron D; Przedborski S; Kholodilov N; Greene LA; Burke RE
J Neurochem; 2005 Nov; 95(4):974-86. PubMed ID: 16135078
[TBL] [Abstract][Full Text] [Related]
4. CEP11004, a novel inhibitor of the mixed lineage kinases, suppresses apoptotic death in dopamine neurons of the substantia nigra induced by 6-hydroxydopamine.
Ganguly A; Oo TF; Rzhetskaya M; Pratt R; Yarygina O; Momoi T; Kholodilov N; Burke RE
J Neurochem; 2004 Jan; 88(2):469-80. PubMed ID: 14690535
[TBL] [Abstract][Full Text] [Related]
5. Targeted disruption of dual leucine zipper kinase and leucine zipper kinase promotes neuronal survival in a model of diffuse traumatic brain injury.
Welsbie DS; Ziogas NK; Xu L; Kim BJ; Ge Y; Patel AK; Ryu J; Lehar M; Alexandris AS; Stewart N; Zack DJ; Koliatsos VE
Mol Neurodegener; 2019 Nov; 14(1):44. PubMed ID: 31775817
[TBL] [Abstract][Full Text] [Related]
6. K252a prevents nigral dopaminergic cell death induced by 6-hydroxydopamine through inhibition of both mixed-lineage kinase 3/c-Jun NH2-terminal kinase 3 (JNK3) and apoptosis-inducing kinase 1/JNK3 signaling pathways.
Pan J; Wang G; Yang HQ; Hong Z; Xiao Q; Ren RJ; Zhou HY; Bai L; Chen SD
Mol Pharmacol; 2007 Dec; 72(6):1607-18. PubMed ID: 17855652
[TBL] [Abstract][Full Text] [Related]
7. Regulation of axotomy-induced dopaminergic neuron death and c-Jun phosphorylation by targeted inhibition of cdc42 or mixed lineage kinase.
Crocker SJ; Hayley SP; Smith PD; Mount MP; Lamba WR; Callaghan SM; Slack RS; Park DS
J Neurochem; 2006 Jan; 96(2):489-99. PubMed ID: 16336220
[TBL] [Abstract][Full Text] [Related]
8. Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family.
Maroney AC; Finn JP; Connors TJ; Durkin JT; Angeles T; Gessner G; Xu Z; Meyer SL; Savage MJ; Greene LA; Scott RW; Vaught JL
J Biol Chem; 2001 Jul; 276(27):25302-8. PubMed ID: 11325962
[TBL] [Abstract][Full Text] [Related]
9. JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degeneration.
Ries V; Silva RM; Oo TF; Cheng HC; Rzhetskaya M; Kholodilov N; Flavell RA; Kuan CY; Rakic P; Burke RE
J Neurochem; 2008 Dec; 107(6):1578-88. PubMed ID: 19014392
[TBL] [Abstract][Full Text] [Related]
10. Mixed lineage kinase-c-jun N-terminal kinase signaling pathway: a new therapeutic target in Parkinson's disease.
Silva RM; Kuan CY; Rakic P; Burke RE
Mov Disord; 2005 Jun; 20(6):653-64. PubMed ID: 15719422
[TBL] [Abstract][Full Text] [Related]
11. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of mixed lineage kinase 3 attenuates MPP+-induced neurotoxicity in SH-SY5Y cells.
Mathiasen JR; McKenna BA; Saporito MS; Ghadge GD; Roos RP; Holskin BP; Wu ZL; Trusko SP; Connors TC; Maroney AC; Thomas BA; Thomas JC; Bozyczko-Coyne D
Brain Res; 2004 Apr; 1003(1-2):86-97. PubMed ID: 15019567
[TBL] [Abstract][Full Text] [Related]
13. Identification of structural and functional domains in mixed lineage kinase dual leucine zipper-bearing kinase required for complex formation and stress-activated protein kinase activation.
Nihalani D; Merritt S; Holzman LB
J Biol Chem; 2000 Mar; 275(10):7273-9. PubMed ID: 10702297
[TBL] [Abstract][Full Text] [Related]
14. Mixed lineage kinase-dependent JNK activation is governed by interactions of scaffold protein JIP with MAPK module components.
Nihalani D; Meyer D; Pajni S; Holzman LB
EMBO J; 2001 Jul; 20(13):3447-58. PubMed ID: 11432832
[TBL] [Abstract][Full Text] [Related]
15. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of bee venom pharmaceutical acupuncture in acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
Doo AR; Kim ST; Kim SN; Moon W; Yin CS; Chae Y; Park HK; Lee H; Park HJ
Neurol Res; 2010 Feb; 32 Suppl 1():88-91. PubMed ID: 20034453
[TBL] [Abstract][Full Text] [Related]
17. Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta.
Boyd JD; Jang H; Shepherd KR; Faherty C; Slack S; Jiao Y; Smeyne RJ
Brain Res; 2007 Oct; 1175():107-16. PubMed ID: 17884023
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
Shin JY; Park HJ; Ahn YH; Lee PH
J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
[TBL] [Abstract][Full Text] [Related]
19. Stress-induced vesicular assemblies of dual leucine zipper kinase are signaling hubs involved in kinase activation and neurodegeneration.
Tortosa E; Sengupta Ghosh A; Li Q; Wong WR; Hinkle T; Sandoval W; Rose CM; Hoogenraad CC
EMBO J; 2022 Jul; 41(14):e110155. PubMed ID: 35611591
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotection in Parkinson models varies with toxin administration protocol.
Anderson DW; Bradbury KA; Schneider JS
Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
